COM:DAYONEBIO
Day One Bio
- Stock
locale
United States
market
STOCKSindustry
Biopharmaceuticalswebsite
dayonebio.comcrunchbase
day-one-biopharmaceuticalslinkedin
dayonebiofounding date
Nov 01, 2018ipo date
May 27, 2021
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/progressive ...Show More